Elanco Animal Health Inc (ELAN) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Elanco Animal Health reported revenue of $4.71B, up 6.2% from $4.44B the year before. Net income was -$232.0M (a -4.9% net margin), or -$0.47 per diluted share. Gross margin was 55.0% and operating margin was 10.2%. Operating activities generated $560.0M of cash, leaving $284.0M of free cash flow. At fiscal year end, Elanco Animal Health held $13.36B in total assets against $6.81B in total liabilities, including $545.0M of cash and equivalents.
Open the full interactive Elanco Animal Health financials → Quarterly statements, key ratios, valuation history and price charts.
Elanco Animal Health Key Stats
| Share Price | $22.41 |
|---|---|
| Market Cap | $11.34B |
| Revenue YoY Growth | +6.2% |
| 52-Week Range | $19.80 – $26.84 |
| Shares Outstanding | 499.5 million (basic, 2026 Q2) |
Elanco Animal Health Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $3.27B | $4.76B | $4.41B | $4.42B | $4.44B | $4.71B |
| Cost of Goods Sold | $1.67B | $2.13B | $1.91B | $1.93B | $2.00B | $2.12B |
| Gross Profit | $1.61B | $2.63B | $2.50B | $2.49B | $2.44B | $2.59B |
| Operating Income | $1.12B | $610.0M | $711.0M | $667.0M | $542.0M | $481.0M |
| Pre-Tax Income | -$672.0M | -$567.0M | -$72.0M | -$1.20B | $488.0M | -$224.0M |
| Income Tax | -$111.9M | -$95.0M | $6.0M | $36.0M | $150.0M | $8.0M |
| Net Income | -$560.1M | -$472.0M | -$78.0M | -$1.23B | $338.0M | -$232.0M |
| Diluted EPS | -$1.27 | -$0.97 | -$0.16 | -$2.50 | $0.68 | -$0.47 |
Elanco Animal Health Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1.14B | $1.14B | $1.37B | $1.37B |
| Net Income | -$34.0M | -$276.0M | $57.0M | $54.0M |
| Diluted EPS | -$0.07 | -$0.56 | $0.11 | $0.11 |
Elanco Animal Health Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $494.7M | $638.0M | $345.0M | $352.0M | $468.0M | $545.0M |
| Current Assets | $3.42B | $3.28B | $3.28B | $3.41B | $3.21B | $3.46B |
| Total Assets | $17.69B | $16.48B | $15.49B | $14.36B | $12.61B | $13.36B |
| Current Liabilities | $2.08B | $1.64B | $1.70B | $1.24B | $1.31B | $1.60B |
| Total Long-Term Debt | $6.13B | $6.32B | $5.84B | $5.77B | $4.32B | $4.02B |
| Total Liabilities | $9.22B | $8.95B | $8.20B | $8.14B | $6.52B | $6.81B |
| Shareholders' Equity | $8.48B | $7.54B | $7.29B | $6.22B | $6.10B | $6.55B |
Elanco Animal Health Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$41.0M | $483.0M | $452.0M | $271.0M | $541.0M | $560.0M |
| Cash From Investing | -$4.78B | -$530.0M | -$179.0M | -$169.0M | $1.16B | -$279.0M |
| Cash From Financing | $4.95B | $210.0M | -$549.0M | -$83.0M | -$1.49B | -$275.0M |
| Free Cash Flow | -$175.6M | $357.0M | $315.0M | $131.0M | $394.0M | $284.0M |
Figures from Elanco Animal Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Elanco Animal Health financials page for every line item.
Elanco Animal Health Company Profile
| Ticker | ELAN |
|---|---|
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Headquarters | Indianapolis, Indiana |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001739104 |
Frequently Asked Questions
What was Elanco Animal Health's revenue in fiscal 2025?
Elanco Animal Health (ELAN) reported revenue of $4.71B for fiscal 2025.
What is Elanco Animal Health's annual revenue history?
Elanco Animal Health's annual revenue by fiscal year: 2020: $3.27B; 2021: $4.76B; 2022: $4.41B; 2023: $4.42B; 2024: $4.44B; 2025: $4.71B.
What was Elanco Animal Health's net income in fiscal 2025?
Elanco Animal Health reported net income of -$232.0M for fiscal 2025.
What was Elanco Animal Health's earnings per share (EPS) in fiscal 2025?
Elanco Animal Health's diluted EPS was -$0.47 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Elanco Animal Health generate in fiscal 2025?
Elanco Animal Health generated $284.0M of free cash flow in fiscal 2025.
What was Elanco Animal Health's revenue last quarter?
In its most recent reported quarter (2026 Q2), Elanco Animal Health reported revenue of $1.37B.
How much debt does Elanco Animal Health have?
Elanco Animal Health reported $4.02B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Elanco Animal Health are outstanding?
Elanco Animal Health reported a weighted average of 499.5 million basic shares outstanding in 2026 Q2.
What is Elanco Animal Health's market cap?
Based on its latest closing price, Elanco Animal Health (ELAN) has a market capitalization of about $11.34B.
When does Elanco Animal Health's fiscal year end?
Elanco Animal Health's fiscal year end, as registered with the SEC, is December 31.
Where is Elanco Animal Health headquartered?
Elanco Animal Health lists its business address in Indianapolis, Indiana in its SEC filings.